Biocept, Inc.
NASDAQ: BIOC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Darrell Taylor
- Employees
- 50
- Headquarters
- San Diego, United States
- IPO year
- 2014
- Market cap
- $450.8K
- Website
- https://biocept.com
Loading BIOC…
Loading profile data…Frequently asked questions about BIOC
What does Biocept, Inc. (BIOC) do?
Biocept, Inc. is a company specializing in molecular diagnostics for cancer, primarily focused on developing and commercializing advanced diagnostic assays based on proprietary technology. These tests analyze circulating tumor cells (CTCs) and cell-free tumor DNA and RNA (ctDNA/ctRNA), primarily using standard blood samples. These assays furnish...
Where does BIOC trade?
Biocept, Inc. (BIOC) trades on the NASDAQ Capital Market.
What sector is BIOC in?
Biocept, Inc. (BIOC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Biocept, Inc.?
Darrell Taylor is the chief executive officer of Biocept, Inc. (BIOC).
Where is Biocept, Inc. headquartered?
Biocept, Inc. is headquartered in United States.
Does BIOC pay a dividend?
Biocept, Inc. (BIOC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOC go public?
Biocept, Inc. (BIOC) completed its initial public offering in 2014.